Balance Sheet
Accounts PayablesAccumulated ExpensesCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwill & IntangiblesInventoryLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Work In Process: 2023-2024

  • Zhengye Biotechnology Holding's Work In Process fell 2.89% to $4.5 million in Q4 2024 from the same period last year, while for Dec 2024 it was $4.5 million, marking a year-over-year decrease of 2.89%. This contributed to the annual value of $4.5 million for FY2024, which is 4.69% down from last year.
  • According to the latest figures from Q4 2024, Zhengye Biotechnology Holding's Work In Process is $4.5 million, which was down 2.89% from $4.7 million recorded in Q4 2023.
  • Zhengye Biotechnology Holding's Work In Process' 5-year high stood at $4.7 million during Q4 2023, with a 5-year trough of $4.5 million in Q4 2024.
  • Moreover, its 2-year median value for Work In Process was $4.6 million (2023), whereas its average is $4.6 million.
  • Data for Zhengye Biotechnology Holding's Work In Process shows a maximum YoY declined of 2.89% (in 2024) over the last 5 years.
  • Zhengye Biotechnology Holding's Work In Process (Quarterly) stood at $4.7 million in 2023, then dropped by 2.89% to $4.5 million in 2024.